About: Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Sector: Healthcare
Industry: Drug Manufacturers - General
Latest price: $11.57 (+0.52%)
AMRN NASDAQ Amarin Corporation PLC
Amarin Corporation PLC share price
Atividade de preço de AMRN
Último preço
$ 11,570
Variação (24h)
0,06 USD (0,52%)
Volume
25.48K
Volume (média 4 sem.)
-
Abertura
$ 11,40
Variação do dia
$ 11,25 - $ 11,65
Fechamento anterior
$ 11,51
Último negócio
22 Oct, 8:00 pm GMT+0
Atrasado
22 Oct, 8:00 pm GMT+0
AMRN price performance
Atrasado
22 Oct, 8:00 pm GMT+0
quote.marketSignals